SitesBLAST
Comparing WP_010963544.1 NCBI__GCF_000008765.1:WP_010963544.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
Q988B8 Pyridoxamine--pyruvate transaminase; Pyridoxamine-pyruvate aminotransferase; EC 2.6.1.30 from Mesorhizobium japonicum (strain LMG 29417 / CECT 9101 / MAFF 303099) (Mesorhizobium loti (strain MAFF 303099)) (see 2 papers)
34% identity, 90% coverage: 5:342/377 of query aligns to 12:353/393 of Q988B8
- E68 (= E62) binding pyridoxal 5'-phosphate; mutation E->A,G: Low but detectable pyridoxamine--pyruvate transaminase activity.
- Y95 (≠ F89) binding pyridoxal 5'-phosphate
- T146 (= T140) binding pyridoxal 5'-phosphate
- K197 (= K191) modified: N6-(pyridoxal phosphate)lysine; mutation to L: Loss of function.
- C198 (= C192) mutation to A: No effect on enzyme activity.
- R336 (≠ F325) mutation to A: Strongly decreased affinity for pyruvate.
- R345 (= R334) binding pyridoxal 5'-phosphate
Sites not aligning to the query:
- 1 modified: Initiator methionine, Removed
2z9xA Crystal structure of pyridoxamine-pyruvate aminotransferase complexed with pyridoxyl-l-alanine (see paper)
34% identity, 90% coverage: 5:342/377 of query aligns to 11:352/392 of 2z9xA
2z9wA Crystal structure of pyridoxamine-pyruvate aminotransferase complexed with pyridoxal (see paper)
34% identity, 90% coverage: 5:342/377 of query aligns to 11:352/392 of 2z9wA
2z9vA Crystal structure of pyridoxamine-pyruvate aminotransferase complexed with pyridoxamine (see paper)
34% identity, 90% coverage: 5:342/377 of query aligns to 11:352/392 of 2z9vA
6mfbD Crystal structure of 3-hydroxykynurenine transaminase from aedes aegypti
30% identity, 94% coverage: 5:359/377 of query aligns to 20:381/386 of 6mfbD
- binding pyridoxal-5'-phosphate: S77 (≠ E62), A78 (≠ G63), H79 (≠ I64), W104 (≠ F89), S154 (≠ T140), D179 (= D165), V181 (= V167), Q204 (= Q190), K205 (= K191), Y256 (≠ F238), T259 (= T241)
Q0IG34 3-hydroxykynurenine transaminase; 3-hydroxykynurenine transaminase and alanine--glyoxylate aminotransferase; Ae-HKT/AGT; Alanine--glyoxylate aminotransferase; EC 2.6.1.63; EC 2.6.1.44 from Aedes aegypti (Yellowfever mosquito) (Culex aegypti)
30% identity, 96% coverage: 5:367/377 of query aligns to 20:391/400 of Q0IG34
- SAH 77:79 (≠ EGI 62:64) binding in other chain
- S154 (≠ T140) binding in other chain
- Q204 (= Q190) binding in other chain
- K205 (= K191) modified: N6-(pyridoxal phosphate)lysine
- Y256 (≠ F238) binding pyridoxal 5'-phosphate
- T259 (= T241) binding pyridoxal 5'-phosphate
2ch1A Structure of anopheles gambiae 3-hydroxykynurenine transaminase (see paper)
29% identity, 94% coverage: 5:359/377 of query aligns to 19:380/388 of 2ch1A
- binding pyridoxal-5'-phosphate: S76 (≠ E62), A77 (≠ G63), H78 (≠ I64), W103 (≠ F89), S153 (≠ T140), D178 (= D165), V180 (= V167), Q203 (= Q190), K204 (= K191), Y255 (≠ F238), T258 (= T241)
Q7PRG3 3-hydroxykynurenine transaminase; AgHKT; Alanine--glyoxylate aminotransferase; EC 2.6.1.63; EC 2.6.1.44 from Anopheles gambiae (African malaria mosquito) (see paper)
29% identity, 94% coverage: 5:359/377 of query aligns to 20:381/396 of Q7PRG3
- SAH 77:79 (≠ EGI 62:64) binding in other chain
- S154 (≠ T140) binding in other chain
- Q204 (= Q190) binding in other chain
- K205 (= K191) modified: N6-(pyridoxal phosphate)lysine
- Y256 (≠ F238) binding pyridoxal 5'-phosphate
- T259 (= T241) binding pyridoxal 5'-phosphate
2ch2A Structure of the anopheles gambiae 3-hydroxykynurenine transaminase in complex with inhibitor (see paper)
29% identity, 94% coverage: 5:359/377 of query aligns to 18:379/387 of 2ch2A
- binding 4-(2-aminophenyl)-4-oxobutanoic acid: G23 (= G10), S41 (≠ P29), N42 (≠ D30), S152 (≠ T140), Y254 (≠ F238), Q342 (≠ A322), L345 (≠ F325), R354 (= R334)
- binding pyridoxal-5'-phosphate: S75 (≠ E62), A76 (≠ G63), H77 (≠ I64), W102 (≠ F89), S152 (≠ T140), D177 (= D165), V179 (= V167), K203 (= K191), Y254 (≠ F238), T257 (= T241)
5hhyA Structure of human alanine:glyoxylate aminotransferase major allele (agt-ma) showing x-ray induced reduction of plp internal aldimine to 4'-deoxy-piridoxine-phosphate (plr) (see paper)
28% identity, 94% coverage: 5:360/377 of query aligns to 19:381/385 of 5hhyA
- binding (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl dihydrogen phosphate: S76 (≠ E62), G77 (= G63), H78 (≠ I64), W103 (≠ F89), S153 (≠ T140), D178 (= D165), V180 (= V167), Q203 (= Q190), K204 (= K191), Y255 (≠ F238), T258 (= T241)
3islA Crystal structure of ureidoglycine-glyoxylate aminotransferase (pucg) from bacillus subtilis
29% identity, 94% coverage: 6:358/377 of query aligns to 10:365/387 of 3islA
P21549 Alanine--glyoxylate aminotransferase; AGT; Serine--pyruvate aminotransferase; SPT; EC 2.6.1.44; EC 2.6.1.51 from Homo sapiens (Human) (see 24 papers)
28% identity, 94% coverage: 5:360/377 of query aligns to 24:386/392 of P21549
- R36 (≠ N17) to C: in HP1; associated in cis with L-11 and M-340; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177157
- G41 (≠ R22) to E: in HP1; loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177168; to R: in HP1; associated in cis with L-11 and M-340; results in loss of protein stability; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; partial mitochondrial mistargeting; intraperoxisomal protein aggregation seen; dbSNP:rs121908523; to V: in HP1; reduced alanine--glyoxylate aminotransferase activity; no loss of dimerization; no effect on protein stability; dbSNP:rs180177168
- G47 (≠ N28) to R: in HP1; associated in cis with L-11 and M-340; results in protein misfolding; decreased alanine--glyoxylate aminotransferase activity; reduced expression levels; reduced pyridoxal phosphate binding; reduced dimerization; reduced thermostability; increased propensity to aggregation; increased susceptibility to proteolytic degradation within the N-terminal region; mitochondrial mistargeting; exposure to pyridoxine can rescue the functionality by partially preventing aggregation and degradation and by redirecting all the protein to the peroxisome; dbSNP:rs180177173
- G82 (= G63) to E: in HP1; abolishes alanine--glyoxylate aminotransferase activity by interfering with pyridoxal phosphate binding; dbSNP:rs121908522
- W108 (≠ F89) to R: in HP1; associated in cis with L-11 and M-340; results in loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; decreased protein stability; dbSNP:rs180177197
- A112 (≠ F93) to D: in HP1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; decreased protein stability; causes protein aggregation; dbSNP:rs796052061
- L150 (≠ Y132) to P: in HP1; associated in cis with L-11 and M-340; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177222
- F152 (≠ T134) to I: in HP1; associated in cis with L-11 and M-340; results in protein destabilization; no loss of dimerization; decreased alanine--glyoxylate aminotransferase activity; loss of alanine--glyoxylate aminotransferase activity when associated with L-11 and M-340; mitochondrial mistargeting when associated with L-11 and M-340; dbSNP:rs121908524
- G156 (≠ C138) to R: in HP1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; decreased protein stability; dbSNP:rs121908530
- S158 (≠ T140) to L: in HP1; loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177225
- G161 (= G143) to C: in HP1; associated in cis with L-11 and M-340; results in loss of alanine--glyoxylate aminotransferase activity; reduced expression levels; decreased protein stability; protein aggregation seen in the cytosol with a decreased aggregation propensity in the presence of pyridoxal phosphate; reduced peroxisomal localization; dbSNP:rs180177227; to R: in HP1; loss of alanine--glyoxylate aminotransferase activity; reduced expression levels; decreased protein stability; protein aggregation seen in the cytosol with a decreased aggregation propensity in the presence of pyridoxal phosphate; loss of dimerization; dbSNP:rs180177227; to S: in HP1; associated in cis with L-11 and M-340; results in loss of alanine--glyoxylate aminotransferase activity; reduced expression levels; decreased protein stability; protein aggregation seen in the cytosol with a decreased aggregation propensity in the presence of pyridoxal phosphate; reduced peroxisomal localization; dbSNP:rs180177227
- L166 (≠ V148) to P: in HP1; associated in cis with L-11 and M-340; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177230
- G170 (≠ C152) to R: in HP1; associated in cis with L-11 and M-340; decrease in alanine--glyoxylate aminotransferase activity; loss of dimerization; partial loss of protein stability but protein stability increases in the presence of pyridoxal phosphate; causes protein aggregation; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with L-11 and M-340; results in mitochondrial mistargeting when associated with L-11 and M-340; dbSNP:rs121908529
- C173 (≠ L155) to Y: in HP1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; decreased protein stability; causes protein aggregation; dbSNP:rs180177231
- D183 (= D165) to N: in HP1; loss of alanine--glyoxylate aminotransferase activity; no loss of dimerization; no effect on protein stability; dbSNP:rs180177236
- S187 (≠ A169) to F: in HP1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization but improved dimerization in the presence of pyridoxal phosphate; decreased protein stability; dbSNP:rs180177238
- I202 (= I184) to N: in HP1; uncertain significance; dbSNP:rs536352238
- S205 (≠ G187) to P: in HP1; loss of alanine--glyoxylate aminotransferase activity; decreased protein stability; dbSNP:rs121908520
- K209 (= K191) mutation to R: Affects pyridoxal phosphate binding; loss of alanine--glyoxylate aminotransferase activity.
- S218 (≠ T200) to L: in HP1; loss of alanine--glyoxylate aminotransferase activity; loss of dimerization; no effect on protein stability; dbSNP:rs180177253
- R233 (= R215) to C: in HP1; associated in cis with L-11 and M-340; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs121908526; to H: in HP1; associated in cis with L-11 and M-340; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs121908527
- I244 (≠ L226) to T: in HP1; associated in cis with L-11 and M-340; results in protein misfolding; decreased alanine--glyoxylate aminotransferase activity in vitro; no loss of dimerization; partial mitochondrial mistargeting; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with L-11 and M-340; dbSNP:rs121908525
- C253 (vs. gap) to R: in HP1; associated in cis with L-11 and M-340; results in loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs180177264
- I279 (= I257) to T: in dbSNP:rs140992177
- A280 (≠ L258) to V: in dbSNP:rs73106685
- V326 (= V300) to I: in dbSNP:rs115057148
- I340 (≠ K314) to M: in allele minor; associated in cis with L-11; no effect on alanine--glyoxylate aminotransferase activity in vitro; decreased specific alanine--glyoxylate aminotransferase activity in vitro when associated with L-11; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with L-11 and I-152; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with L-11 and R-170; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with L-11 and T-244; results in mitochondrial mistargeting when associated with L-11 and R-170; dbSNP:rs4426527
Sites not aligning to the query:
- 9 T → N: no loss of alanine--glyoxylate aminotransferase activity; dbSNP:rs115014558
- 11 P → L: in allele minor; associated in cis with M-340; decreased specific alanine--glyoxylate aminotransferase activity in vitro when associated with M-340; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with I-152 and M-340; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with R-170 and M-340; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with T-244 and M-340; causes mitochondrial mistargeting when associated with R-170 and M-340; dbSNP:rs34116584
6rv0A Human alanine:glyoxylate aminotransferase major allele (agt-ma); with pmp in the active site (see paper)
28% identity, 94% coverage: 5:360/377 of query aligns to 19:381/384 of 6rv0A
1j04A Structural mechanism of enzyme mistargeting in hereditary kidney stone disease in vitro (see paper)
28% identity, 94% coverage: 5:360/377 of query aligns to 21:383/387 of 1j04A
1h0cA The crystal structure of human alanine:glyoxylate aminotransferase (see paper)
28% identity, 94% coverage: 5:360/377 of query aligns to 21:381/385 of 1h0cA
- binding (aminooxy)acetic acid: P25 (= P9), G26 (= G10), L346 (≠ F325), R355 (= R334)
- binding pyridoxal-5'-phosphate: S78 (≠ E62), G79 (= G63), H80 (≠ I64), W105 (≠ F89), S153 (≠ T140), D178 (= D165), V180 (= V167), K204 (= K191)
Sites not aligning to the query:
Q3LSM4 Alanine--glyoxylate aminotransferase; EC 2.6.1.44 from Aedes aegypti (Yellowfever mosquito) (Culex aegypti) (see paper)
29% identity, 94% coverage: 5:358/377 of query aligns to 21:380/393 of Q3LSM4
- SGH 78:80 (≠ EGI 62:64) binding in other chain
- S155 (≠ T140) binding glyoxylate; binding L-alanine
- Q205 (= Q190) binding in other chain
- K206 (= K191) modified: N6-(pyridoxal phosphate)lysine
- Y257 (≠ F238) binding pyridoxal 5'-phosphate
- T260 (= T241) binding pyridoxal 5'-phosphate
- R356 (= R334) binding glyoxylate
2huuA Crystal structure of aedes aegypti alanine glyoxylate aminotransferase in complex with alanine (see paper)
29% identity, 94% coverage: 5:358/377 of query aligns to 21:380/385 of 2huuA
2huiA Crystal structure of aedes aegypti alanine glyoxylate aminotransferase in complex with glyoxylic acid (see paper)
29% identity, 94% coverage: 5:358/377 of query aligns to 21:380/385 of 2huiA
2hufA Crystal structure of aedes aegypti alanine glyoxylate aminotransferase (see paper)
29% identity, 94% coverage: 5:358/377 of query aligns to 21:380/385 of 2hufA
O32148 (S)-ureidoglycine--glyoxylate transaminase; UGXT; (S)-ureidoglycine--glyoxylate aminotransferase; Purine catabolism protein PucG; EC 2.6.1.112 from Bacillus subtilis (strain 168) (see paper)
28% identity, 94% coverage: 6:358/377 of query aligns to 14:387/416 of O32148
- Q37 (≠ D30) mutation to H: 5-fold decrease in transamination activity.
- K198 (= K191) modified: N6-(pyridoxal phosphate)lysine
- N264 (vs. gap) mutation to S: 9-fold decrease in transamination activity.; mutation to Y: Loss of transamination activity.
Query Sequence
>WP_010963544.1 NCBI__GCF_000008765.1:WP_010963544.1
MKVPIIMTPGPTSVRENVRLSRAEKTTNPDLDMDFYDFYKKTTEKIGKFLKTKNEVRILS
GEGILGLEAACASLTEKGDRVLVIENGIFGEGFADFVKMYGGEPFFFRGNKKCSINIEEL
ERFLDSDSEFKYATVVHCDTPSGMLNNVGAICKLLKKKGIMTVVDSVSAMGGEELKVDEW
DIDIVIGGSQKCISAPPGLTIVSISDDAFSAMKNRKTPIASFYCNLLVWEDYYNKKWFPY
TPPISDIVALRKAVENILEEKDIIARHDKIASATRAAVVLGGLEIYIEDGFSNTVTVIKV
PHGMNDDKILSYMKENYNVMIAGAFDYLKGKVLRIGHMGENAYVDKVSYTLFALQRTLEH
YGFEFKRDMVKVFLEKV
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory